{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:18:39Z","timestamp":1697275119067},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.leukres.2008.09.025","type":"journal-article","created":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T22:01:23Z","timestamp":1225836083000},"page":"829-836","source":"Crossref","is-referenced-by-count":11,"title":["PDTC enables type I TRAIL signaling in type II follicular lymphoma cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Ulla","family":"Nuutinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niina","family":"Simelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Ropponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonna","family":"Eeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"M\u00e4tt\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Eray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riikka","family":"Pellinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Wahlfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jukka","family":"Pelkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.09.025_bib1","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.leukres.2008.09.025_bib2","first-page":"321","article-title":"High-dose therapy for follicular lymphoma","volume":"14","author":"Freedman","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.leukres.2008.09.025_bib3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1084\/jem.167.3.1067","article-title":"The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity","volume":"167","author":"Havell","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2008.09.025_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/364806a0","article-title":"Lethal effect of the anti-Fas antibody in mice","volume":"364","author":"Ogasawara","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.09.025_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2008.09.025_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/drup.2001.0208","article-title":"Potential and caveats of TRAIL in cancer therapy","volume":"4","author":"Held","year":"2001","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.leukres.2008.09.025_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/A:1020039225764","article-title":"TNF-related apoptosis inducing ligand (TRAIL) and its receptors in tumor surveillance and cancer therapy","volume":"7","author":"Wajant","year":"2002","journal-title":"Apoptosis"},{"key":"10.1016\/j.leukres.2008.09.025_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2008.09.025_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1074-7613(00)80400-8","article-title":"Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway","volume":"7","author":"Chaudhary","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2008.09.025_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.276.5309.111","article-title":"The receptor for the cytotoxic ligand TRAIL","volume":"276","author":"Pan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2008.09.025_bib11","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1093\/emboj\/16.17.5386","article-title":"TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL","volume":"16","author":"Walczak","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2008.09.025_bib12","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.025_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0960-9822(06)00422-2","article-title":"A novel receptor for Apo2L\/TRAIL contains a truncated death domain","volume":"7","author":"Marsters","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/j.leukres.2008.09.025_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","volume":"277","author":"Pan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.leukres.2008.09.025_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/35008667","article-title":"TRAIL receptor-2 signals apoptosis through FADD and caspase-8","volume":"2","author":"Bodmer","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.leukres.2008.09.025_bib16","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2008.09.025_bib17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","article-title":"Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5","volume":"12","author":"Kischkel","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2008.09.025_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1074-7613(00)80211-3","article-title":"FADD\/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2","volume":"12","author":"Sprick","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2008.09.025_bib19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/Fas) signaling pathways","volume":"17","author":"Scaffidi","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2008.09.025_bib20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis","volume":"94","author":"Li","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","article-title":"Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors","volume":"94","author":"Luo","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)80501-2","article-title":"Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3","volume":"90","author":"Zou","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1097-2765(00)80095-7","article-title":"Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization","volume":"1","author":"Srinivasula","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib25","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1074\/jbc.274.17.11549","article-title":"An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9","volume":"274","author":"Zou","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.025_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(00)00008-8","article-title":"Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition","volume":"102","author":"Du","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1074\/jbc.M109784200","article-title":"The serine protease Omi\/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif","volume":"277","author":"Martins","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.025_bib28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1097-2765(01)00341-0","article-title":"A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death","volume":"8","author":"Suzuki","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(00)00009-X","article-title":"Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins","volume":"102","author":"Verhagen","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2008.09.025_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1074\/jbc.M109891200","article-title":"HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins","volume":"277","author":"Verhagen","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.025_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1096\/fasebj.14.5.729","article-title":"Mitochondria-nuclear translocation of AIF in apoptosis and necrosis","volume":"14","author":"Daugas","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.leukres.2008.09.025_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/17135","article-title":"Molecular characterization of mitochondrial apoptosis-inducing factor","volume":"397","author":"Susin","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.09.025_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/35083620","article-title":"Endonuclease G is an apoptotic DNase when released from mitochondria","volume":"412","author":"Li","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.09.025_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/35083608","article-title":"Mitochondrial endonuclease G is important for apoptosis in C. elegans","volume":"412","author":"Parrish","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2008.09.025_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.neo.7900270","article-title":"Defining characteristics of Types I and II apoptotic cells in response to TRAIL","volume":"4","author":"Ozoren","year":"2002","journal-title":"Neoplasia"},{"key":"10.1016\/j.leukres.2008.09.025_bib36","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/sj.onc.1204282","article-title":"Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways","volume":"20","author":"Suliman","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.025_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.onc.1208191","article-title":"Type I and type II reactions in TRAIL-induced apoptosis\u2014results from dose-response studies","volume":"24","author":"Rudner","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.025_bib38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-3083.2003.01264.x","article-title":"Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells","volume":"57","author":"Eray","year":"2003","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.leukres.2008.09.025_bib39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-3083.2005.01624.x","article-title":"CD45RA and RO isoforms have distinct effects on cytokine- and B-cell-receptor-mediated signalling in human B cells","volume":"61","author":"Matto","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.leukres.2008.09.025_bib40","first-page":"322","article-title":"Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line","volume":"312","author":"Nuutinen","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.leukres.2008.09.025_bib41","first-page":"1753","article-title":"Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy","volume":"25","author":"Pellinen","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.leukres.2008.09.025_bib42","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/sj.onc.1205258","article-title":"Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression","volume":"21","author":"Fulda","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.025_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(00)01375-2","article-title":"Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis","volume":"471","author":"Keogh","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.leukres.2008.09.025_bib44","first-page":"187","article-title":"Failure of Bcl-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand","volume":"18","author":"Kim","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1016\/j.leukres.2008.09.025_bib45","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1242\/jcs.114.23.4161","article-title":"Wild-type, mitochondrial and ER-restricted Bcl-2 inhibit DNA damage-induced apoptosis but do not affect death receptor-induced apoptosis","volume":"114","author":"Rudner","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.leukres.2008.09.025_bib46","first-page":"3051","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells","volume":"60","author":"Walczak","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2008.09.025_bib47","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1038\/sj.onc.1203936","article-title":"Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis","volume":"19","author":"Hinz","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.025_bib48","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1038\/sj.onc.1204504","article-title":"TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhabitable by Bcl-2","volume":"20","author":"Munshi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.025_bib49","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/sj.onc.1204410","article-title":"Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis","volume":"20","author":"Rokhlin","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.025_bib50","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1038\/sj.onc.1204887","article-title":"The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels","volume":"20","author":"Ruiz de Almodovar","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2008.09.025_bib51","doi-asserted-by":"crossref","first-page":"36152","DOI":"10.1074\/jbc.C000533200","article-title":"Molecular determinants of the caspase-promoting activity of Smac\/DIABLO and its role in the death receptor pathway","volume":"275","author":"Srinivasula","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.025_bib52","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1006\/bbrc.2000.4218","article-title":"Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells","volume":"280","author":"Sun","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.leukres.2008.09.025_bib53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.leukres.2005.08.022","article-title":"HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells","volume":"30","author":"Skommer","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.09.025_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/emboj\/17.1.37","article-title":"Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization","volume":"17","author":"Bossy-Wetzel","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.leukres.2008.09.025_bib55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1083\/jcb.153.2.319","article-title":"Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process","volume":"153","author":"Waterhouse","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.leukres.2008.09.025_bib56","doi-asserted-by":"crossref","first-page":"29652","DOI":"10.1074\/jbc.M603487200","article-title":"Loss of caspase-9 provides genetic evidence for the type I\/II concept of CD95-mediated apoptosis","volume":"281","author":"Samraj","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.leukres.2008.09.025_bib57","first-page":"6259","article-title":"The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand","volume":"60","author":"Ozoren","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2008.09.025_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1101\/gad.949602","article-title":"TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac\/DIABLO","volume":"16","author":"Deng","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.leukres.2008.09.025_bib59","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02893359","article-title":"Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of Smac\/DIABLO from the mitochondria","volume":"12","author":"Nagy","year":"2006","journal-title":"Pathol Oncol Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608004542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T22:50:27Z","timestamp":1632091827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608004542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0145212608004542"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.09.025","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}